CPHI vs HCA · rev $4.1M vs P/E 17, rev $75.60B
China Pharma Holdings Inc (CPHI) versus HCA Holdings Inc (HCA) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
CPHI currently screens at market cap $29.0M. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Not investment advice. Open the CPHI and HCA stock pages for the full models.
Not investment advice.